Search
for
Sort by
Research 121–150 of 1000+
- Cardiovascular risk factors and events in women with androgen excess
- Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight
- Is acne a sign of androgen excess disorder or not?
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Managing polycystic ovary syndrome in primary care
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Vitamin B<sub>3</sub> (niacin), B<sub>6</sub>, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
- Polycystic ovary syndrome
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- A Novel Androgen Receptor Gene Mutation in a 46,XY Patient: Complete Androgen Insensitivity Syndrome
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- A Comprehensive Review of Management of Patients with Infertility having Polycystic Ovarian Syndrome
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Advances in Knowledge of Androgens: How Intentional and Accidental Neurosteroid Changes Inform Us of Their Action and Role
- Management of teenagers with polycystic ovarian syndrome
- Polycystic ovarian syndrome
- History and physical examination of polycystic ovary syndrome: Detecting too much or too little
- Androgens in SARS-CoV-2 Coronavirus Infections
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Polycystic Ovarian Syndrome in Adolescents
- The Value of Androgen Measures for Diagnosing Polycystic Ovary Syndrome (PCOS) in an Unselected Population
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- An adolescent girl presenting with primary amenorrhea: A case report of complete androgen insensitivity syndrome
- Comparison of Clinical and Biochemical Markers of Hirsutism in Polycystic Ovary Syndrome – A Study from a Teaching Hospital in Sri Ramachandra Institute, Chennai, India
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies